As thousands of Americans linger on AIDS drug waiting lists for access to lifesaving AIDS medications, Gilead announces $10.4 billion all-cash purchase of rival company, Pharmasset In 2010, Gilead had …
Questions on Tactic to Prevent H.I.V.
By: David Tuller, The New York Times New York, NY – October 10, 2011 In the past year, three landmark clinical trials have shown that a daily dose of the antiretroviral medication …
